26.02.2010 • News

German Chemicals Group Brenntag Plans IPO

German chemical distributor Brenntag is aiming for an initial public offering in the first half of 2010, most likely before the Easter holidays in early April, two people familiar with the matter told Reuters. Brenntag had no immediate comment.

Brenntag, bought by private equity group BC Partners for more than €3 billion in 2006, had sales of €7.4 billion in 2008 and has about 11,000 employees in more than 64 countries.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

Article

The State of the US Specialty Chemicals Industry
Reshaping Specialty Chemicals Manufacturing

The State of the US Specialty Chemicals Industry

SOCMA's Jenn Klein examines how specialty chemical manufacturers — the invisible backbone behind pharmaceuticals, electronics, agriculture, and energy — are navigating supply chain shifts, policy uncertainty, and constant change while remaining resilient, disciplined, and focused on execution.

most read